
The authors give an overview of scaling approaches and present good scaling practices for the biopharma industry.
William Tran is a senior scientist at Biologics Process R&D, Merck and Co. (MSD outside of the United States and Canada).

The authors give an overview of scaling approaches and present good scaling practices for the biopharma industry.

January 1st 2024